Moderna MRNA
NASDAQ MRNA
$218.00 -18.50 (-7.82%)
As of: Oct 16, 2026 · 3:59 PM EDT

Moderna (MRNA) Cost of Revenue (2020 - 2026)

Updated

Moderna (MRNA) recorded Cost of Revenue of $93 million in Q2 2026, down 21.8% from $119 million a year earlier and down 90.3% from the prior quarter.

Analysis

Moderna (MRNA) Cost of Revenue (2020 - 2026) Analysis & Trends

On a TTM basis, Moderna's Cost of Revenue came in at $1.71 billion as of Jun 30, 2026, up 16.8% year-over-year; for FY2025, it was $868 million, down 40.7% from FY2024.

  • Annual Cost of Revenue has declined for three straight years, though with a five-year compound annual growth rate of 155.3% (FY2020 to FY2025).
  • Across earlier years, Cost of Revenue came in at $1.46 billion in FY2024 (-68.8%), $4.69 billion in FY2023 (-13.3%), $5.42 billion in FY2022 (+107.0%) and $2.62 billion in FY2021.
  • The Q2 2026 figure is the lowest quarterly Cost of Revenue since Q1 2025.
  • On a year-over-year basis, Cost of Revenue rose in two of the last eight quarters, with growth averaging 92.6%.
  • Peak year-over-year performance for Cost of Revenue in the last five years was growth of 961.1% in Q1 2026, against a decline of 87.9% in Q1 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $955 million (Q1 2026), $452 million (Q4 2025) and $207 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 8.05 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 4.29 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 2.52 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn 1.58 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn 4.09 Bn
10 Moderna 85.93 Bn 65.29 Bn 52.00 Mn 93.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 93.00 Mn
Mar 31, 2026 955.00 Mn
Dec 31, 2025 452.00 Mn
Sep 30, 2025 207.00 Mn
Jun 30, 2025 119.00 Mn
Mar 31, 2025 90.00 Mn
Dec 31, 2024 739.00 Mn
Sep 30, 2024 514.00 Mn
Jun 30, 2024 115.00 Mn
Mar 31, 2024 96.00 Mn
Dec 31, 2023 929.00 Mn
Sep 30, 2023 2.24 Bn
Jun 30, 2023 731.00 Mn
Mar 31, 2023 792.00 Mn
Dec 31, 2022 1.92 Bn
Sep 30, 2022 1.10 Bn
Jun 30, 2022 1.38 Bn
Mar 31, 2022 1.02 Bn
Dec 31, 2021 952.00 Mn
Sep 30, 2021 722.00 Mn
API Access

Moderna Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=MRNA&period=max&api_key=YOUR_API_KEY